Retrospective Study in Sarcoma Patients

Updated 04/30/2024

Status Completed

Clinical Trial Summary

The objectives of this trial is to evaluate efficacy and safety of treatment with Trabectedin in a large cohort of German patients with soft tissue and bone sarcomas.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03284320
Study type	Observational
Source	University Medicine Greifswald
Contact
Status	Completed
Phase
Start date	April 18, 2017
Completion date	November 1, 2021

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT04122872` - GISAR German Interdisciplinary Sarcoma Registry
	Recruiting	`NCT06074692` - PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)	Phase 2
	Recruiting	`NCT04616248` - In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors	Phase 1
	Terminated	`NCT02199938` - Identification and Characterization of Molecular Markers in Musculoskeletal Tumors
	Recruiting	`NCT05057143` - 3D Printed Implants for the Defect Reconstruction in Patients With Chest Wall Tumors	N/A
	Recruiting	`NCT05057130` - Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors	Phase 2/Phase 3
	Terminated	`NCT02775799` - National Swiss Sarcoma Cohort Study